Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar tenmiles (99.97) Submitted: 11/18/2010 2:51:39 PM : Underperform Start Price: $16.04 JAZZ Score: -176.03

Jazz around $16 making me Dizzy - favors the shorts from here

Featured Broker Partners


Advertisement